PGR and breast cancer: BC is categorized into three major types based on its molecular characteristics: hormone-based BC (estrogen receptor (ER+) or progesterone receptor (PR+)), human epidermal receptor 2-expressing (HER2+) BC, and triple-negative (ER−, PR−, and HER2−) BC (TNBC) [3].